Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1195

1.
2.
4.

Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.

Vantrimpont P, Rouleau JL, Wun CC, Ciampi A, Klein M, Sussex B, Arnold JM, Moyé L, Pfeffer M.

J Am Coll Cardiol. 1997 Feb;29(2):229-36.

5.

[Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].

Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J; Investigadores del PRIAMHO II.

Rev Esp Cardiol. 2006 Apr;59(4):313-20. Spanish.

7.
8.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
9.

Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).

Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.

Am J Cardiol. 2009 Jul 15;104(2):151-7. doi: 10.1016/j.amjcard.2009.03.020. Epub 2009 Jun 3.

PMID:
19576338
10.

Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Peterson JG, Topol EJ, Sapp SK, Young JB, Lincoff AM, Lauer MS.

Am J Med. 2000 Oct 1;109(5):371-7.

PMID:
11020393
11.

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.

PMID:
18041162
13.

[Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].

Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.

Ital Heart J. 2005 Nov;6 Suppl 7:14S-23S. Review. Italian.

PMID:
16485513
14.
15.
17.

Angiotensin-converting enzyme inhibitors post-myocardial infarction.

Young JB.

Cardiol Clin. 1995 Aug;13(3):379-90. Review.

PMID:
7585774
18.

Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.

Kyriakidis M, Antonopoulos A, Georgiou E, Santas P, Bakirtzis C, Toutouzas P.

Eur Heart J. 1996 Jun;17(6):864-73.

PMID:
8781825
19.

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB.

Ann Intern Med. 2002 Oct 1;137(7):555-62.

PMID:
12353942
20.

Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.

Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2009 Apr;20(4):395-400. doi: 10.1111/j.1540-8167.2008.01333.x. Epub 2008 Oct 27.

PMID:
19017351

Supplemental Content

Support Center